Pacific BioLabs is a leading CRO specializing in biocompatibility testing for medical devices, offering comprehensive in vitro, in vivo, and analytical services to ensure product safety and regulatory compliance.
Pacific BioLabs is a premier Contract Research Organization (CRO) dedicated to providing comprehensive biocompatibility testing services for medical devices. They specialize in ensuring that devices and materials are compatible with biological systems, adhering to critical international standards such as ISO 10993. Their expertise spans in vitro testing, including cytotoxicity and extractables/leachables analysis (ISO 10993-18), as well as in vivo testing for skin irritation, sensitization, and implantation. Pacific BioLabs also offers hemolysis testing (ASTM F756) and chemical characterization to support regulatory submissions. With a strong emphasis on quality systems, cGMP/GLP compliance, and continuous improvement, Pacific BioLabs guides manufacturers through the complex process of biocompatibility assessment. They help determine the necessary tests, develop biological evaluation plans (BEPs), and ensure compliance with FDA, EU, and other global regulatory requirements, ultimately prioritizing patient safety.
About
**Who they are** Pacific BioLabs is a Contract Research Organization (CRO) specializing in life science testing, including comprehensive biocompatibility testing for medical devices. They focus on ensuring product safety and regulatory compliance.
**Expertise & scope** * Biocompatibility testing services aligned with ISO 10993 standards. * In vitro testing, including cytotoxicity (MEM Elution, Agarose Overlay, Direct Contact). * In vivo biocompatibility testing. * Extractables and leachables testing, crucial for chemical characterization. * Analytical chemistry services, including ICP-MS trace elemental analysis. * Support for medical device, delivery device, and combination product development. * Services also extend to pharmaceutical and biopharmaceutical manufacturing and development support.
**Reputation / proof points** * FDA registered. * ISO 17025 accredited. * Animal science operations accredited by AAALAC.
Additional information
Pacific BioLabs emphasizes a structured approach to biocompatibility testing, beginning with planning. This involves gathering data on device materials and developing a Biological Evaluation Plan (BEP) to determine necessary tests. They offer a Biocompatibility Planning Tool (BioPT) to assist manufacturers. Testing typically progresses from in vitro screening, such as cytotoxicity, followed by extractables and leachables analysis, and then in vivo testing. Their services are designed to support manufacturers in meeting regulatory requirements and ensuring patient safety.
Key Highlights
Specializes in biocompatibility testing for medical devices, adhering to ISO 10993 standards.
Source
“Biocompatibility is, by definition, a measurement of how compatible a device or material is with a biological system. The ISO 10993-1: 2018 standard defines biocompatibility...”
Offers a range of in vitro tests, including cytotoxicity (MEM Elution, Agarose Overlay, Direct Contact).
Source
“There are three in vitro cytotoxicity tests that PBL performs: MEM Elution, Agarose Overlay, and Direct Contact.”
Performs in vivo biocompatibility testing and extractables/leachables analysis (ISO 10993-18).
Source
“In vivo Biocompatibility Testing; Device Extractables and Leachables – ISO 10993-18”
Biocompatibility testing, Cytotoxicity testing, Extractables and Leachables testing, In vitro testing, In vivo testing, Analytical chemistry, ICP-MS trace elemental analysis